Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding MetLife is 'Strong Buy'. Macroaxis provides MetLife buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MetLife positions. The advice algorithm takes into account all of MetLife available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MetLife buy-and-hold prospective. Please see also MetLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon MetLife has a risk adjusted performance of 0.3363, jensen alpha of 0.1283, total risk alpha of 0.0812, sortino ratio of 0.0446 and treynor ratio of 0.4146MetLife buy or sell recommendations module can be used to check and cross-verify current advice provided by analysts analyzing the firm potential to grow using all of fundamental, technical, data market data available at the time. To make sure MetLife is not overpriced, please verify all MetLife fundamentals including its Debt to Equity, and the relationship between EBITDA and Earnings Per Share . Given that MetLife has Price to Earning of 8.42X, we recommend you check MetLife market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.
MetLife Thematic Classifications
Millennials BestFirms that are involved in making products or providing services to millennials
Top FinTechA collection of large financial service, investment, and banking companies
InsuranceUSA Equities from Insurance industry as classified by Fama & French
MetLife has relatively low volatility with skewness of 0.88 and kurtosis of 3.49. However, we advise all investors to independently investigate MetLife to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
Please see also MetLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.